1. These Regulations prescribe the procedures by which
students are to be exempted from specific State examinations.
2. A student may be exempted from State examinations for the
acquisition of basic education and general secondary education on
the basis of a statement which has been issued by a primary
health care doctor (hereinafter - doctor) with whom the student
is registered and in whose care he or she has been for a time
period of at least six months.
3. The statement shall indicate the diagnosis, which may be
the basis for the exemption of the student from State
examinations (Annex), and the time period of exemption.
4. Each year, the head of a State-founded educational
institution shall, on the basis of the submission of a student or
his or her legal representative, submit the following documents
by 1 April to the Minister to whom the relevant educational
institution is subordinated (the head of an educational
institution founded by a local government and other legal persons
or natural persons - to the relevant educational
administration):
4.1. a submission with a list of such students who are
exempted from the State examinations on the basis of a statement
issued by a doctor;
4.2. summary of absences for the relevant school year,
indicating the reasons for absence and the total number of absent
days.
5. The documents referred to in Sub-paragraph 4.1 of these
Regulations shall be signed and approved with the seal of an
educational institution by the head of the educational
institution.
6. The documents submitted by the head of the State
educational institution, which is subordinate to the Ministry,
shall be examined by a commission approved by the relevant
minister. A decision of the commission regarding the exemption of
a student from State examinations shall be recorded in the
minutes of the commission meeting and an extract of the minutes
shall be sent to the educational institution by 15 April of the
relevant year.
7. Documents submitted by the head of an educational
institution founded by a local government or other legal persons
or natural persons shall be examined by a commission approved by
the chairperson of the district council or republic city council.
The educational administration shall draw up the decision taken
by the referred to commission regarding the exemption of a
student from State examinations as an order of the educational
administration and it shall be sent to the educational
institution by 15 April of the relevant year.
8. The head of an educational institution shall exempt from
State examinations a student of grade 9 or grade 12 who studies
in a special educational institution or general educational
institution in accordance with the requirements of a special
education programme upon the recommendation of the pedagogical
council of the educational institution, co-ordinating the
decision with the State Pedagogical Medical Commission.
9. If a student receives medical treatment in an inpatient
medical treatment establishment, his or her exemption from State
examinations shall be arranged by the head of such educational
institution in which the student has permanently studied.
10. Documents regarding a student who has become ill after 1
April or during the State examination shall be immediately
submitted to the educational administration or the relevant
ministry. If the student recovers during the State examinations
(submits an extract from an outpatient or inpatient medical
treatment card issued by a doctor), he or she may take the other
State examinations in the time period indicated in an order of
the Ministry of Education and Science.
11. A student who has been exempted from the State
examinations in accordance with the procedures prescribed in
these Regulations for a time period which is longer than six
months or permanently is entitled to receive a certificate of
basic education or a diploma of general secondary education if
the rest of the requirements provided in the General Education
Law for receiving the relevant document have been fulfilled.
12. A student who has been exempted from the State
examinations in accordance with the procedures prescribed by
these Regulations for a time period which is less than six months
is entitled to receive a certificate of basic education or a
diploma of general secondary education if he or she has passed
the specified State examinations and the rest of the requirements
provided for in the General Education Law for receiving the
relevant document have been fulfilled.
13. A student who has been exempted from the State
examinations in accordance with the procedures prescribed by
these Regulations is entitled to take the State examinations in
the time period indicated in the order of the Minister for
Education and Science on the basis of a justified submission of
the student or a legal representative thereof to the head of the
educational institution.
14. On the basis of the justified submission of a student or a
legal representative thereof, the student may be exempted from
the State examinations which are not referred to in Paragraph 2
of these Regulations by an order of the head of an educational
institution, indicating the reasons of the exemption therein.
Prime Minister E. Repše
No.
|
Classification number of
disease
|
Diagnosis
|
Term of exemption
|
1
|
2
|
3
|
4
|
1.
|
A 01 |
Typhoid fever and paratyphoid
fever |
3 months after clinical and
laboratory remission |
2.
|
A 02 |
Salmonellosis |
1 month after clinical and
laboratory remission |
3.
|
A 03 |
Shigellosis |
1 month after clinical and
laboratory remission |
4.
|
A 05 |
Botulism |
6 months after clinical and
laboratory remission if the result is positive;
1 year if there is a stable neurological symptomatalogy |
5.
|
A15 -16.9 |
Active tuberculosis of the
respiratory tract, including lungs |
Permanently, with the statement
of a physiopneumatologist |
6.
|
A 17.0 |
Meningitis of tuberculosis |
Permanently, with the statement
of a physiopneumatologist |
7.
|
A18 -19.9 |
Active tuberculosis of other
organs |
Permanently, with the statement
of a physiopneumatologist |
8.
|
A 23 |
Brucellosis |
Permanently |
9.
|
A 27 |
Leptospirosis |
3 months after clinical and
laboratory remission |
10.
|
A 28 |
Extra-intestinal yersinosis |
3 months after clinical and
laboratory remission |
11.
|
A 36 |
Diphtheria |
2 months after clinical and
laboratory remission |
12.
|
A 37 |
Whooping cough |
2 months after clinical and
laboratory remission |
13.
|
A 38 |
Scarlet fever |
1 month after clinical and
laboratory remission |
14.
|
A 69.2 |
Lyme disease |
3 months after clinical and
laboratory remission |
15.
|
A 80 |
Poliomyelitis |
Permanently |
16.
|
B 01 |
Chickenpox |
1 month after clinical and
laboratory remission |
17.
|
B 02 |
Zoster (herpes zoster) |
1 month after clinical and
laboratory remission |
18.
|
B 05 |
Measles |
1 month after clinical and
laboratory remission |
19.
|
B 06 |
German measles |
1 month after clinical and
laboratory remission |
20.
|
B 15 |
Acute A Hepatitis A |
3 months after clinical and
laboratory remission |
21.
|
B 16 |
Acute Hepatitis B |
3 months after clinical and
laboratory remission |
22.
|
B 17 |
Other acute types of
hepatitis |
3 months after clinical and
laboratory remission |
23.
|
B 27 |
Infectious mononucleosis |
2 months after clinical and
laboratory remission |
24.
|
C 00-75 |
Malignant tumours |
Very individually, with the
statement of an oncohaematologist |
25.
|
C 76-80 |
Ill-defined, secondary, and
non-localised malignant tumours |
Very individually, with the
statement of an oncohaematologist |
26.
|
C 81 |
Hodgkin's lymphoma |
Very individually, with the
statement of an oncohaematologist |
27.
|
C 82-85 |
Non-Hodgkin's lymphoma |
Very individually, with the
statement of an oncohaematologist |
28.
|
C 88-90 |
Malignant immunoproliferative
diseases |
Very individually, with the
statement of an oncohaematologist |
29.
|
C 91.0, 92.0-1, 92.4-5, 93.0,
94.2 |
Acute and chronic leukaemia |
Very individually, with the
statement of an oncohaematologist |
30.
|
C 95.0-9 |
Other and unspecified
lymphoidal, haematopoietic malignant tumours and malignant
tumours of related tissues |
Very individually, with the
statement of an oncohaematologist |
31.
|
D 50 62 |
Heavy Iron-deficiency
anaemia |
3 months after clinical and
laboratory remission |
32.
|
D 55 |
Anaemias caused by deficiency of
Er enzymes |
Very individually, with the
statement of an oncohaematologist |
33.
|
D 58.0 |
Microspherocytosis |
Very individually, with the
statement of an oncohaematologist |
34.
|
D 59 |
Immune haemolytic anaemias |
Permanently |
35.
|
D 61.0 -3 |
Aplastic anaemias |
Permanently |
36.
|
D 66, 67, 68 |
Coagulopathies: haemophilia A, B
and C with frequent haemorrhagic crises |
Permanently |
37.
|
D 68.0 |
Von Willebrand's disease, heavy
form |
Very individually, depending on
the severity of the disease, with the statement of a
haematologist |
38.
|
D 68.2 |
Inherited deficiency of other
fibrillation factors with heavy progress |
Very individually, depending on
the severity of the disease, with the statement of a
haematologist |
39.
|
D 69.0 |
Haemorrhagic vasculitis,
complicated by glomerulonephritis |
2 months after clinical and
laboratory remission |
40.
|
D 69.3 |
Idiopathic thrombocytopenic
purpura, chronic form, recurring course |
Very individually, with the
statement of a haematologist |
41.
|
D 76.0 |
Histiocytosis X |
Very individually, with the
statement of a haematologist |
42.
|
D 80.9, D 81 -89.9 |
Immunodeficiencies |
Permanently |
43.
|
E 03 |
Hereditary hypothyroidism |
Permanently |
44.
|
E 04-05 |
Other non-toxic types of goitre
Thyrotoxicosis |
Not less than 6 months after a
subtotal surgical operation on goitre |
45.
|
E 05.1 |
Thyrotoxicosis |
Permanently |
46.
|
E 10.0-9 |
Diabetes |
Permanently |
47.
|
E 20.0, 20.1 |
Idiopathic hypoparathyroidism,
pseudohypoparathyroidism |
Permanently |
48.
|
E 23.0 |
Hypopituitarism (pituitary
nanism) |
Permanently |
49.
|
E 23.2 |
Diabetes insipidus , heavy
form |
Permanently |
50.
|
E 25.0 |
Adrenogenital syndrome (form of
salt loss) |
Permanently |
51.
|
E 27.1 |
Addison's disease |
Permanently |
52.
|
E 27.5 |
Pheochromocytoma |
1 year after discharge from
hospital |
53.
|
E 84 |
Cystic fibrosis
(mucovisvidosis) |
Permanently |
54.
|
F 06.0, F 06.1-3, F 06.8, F
30-34, F 38, F 39, F 43.0, F 44.2, 3, 8, F 09 |
Other psychoses, affective
disorders, epileptic psychoses |
Very individually, with the
statement of a psychiatrist |
55.
|
F 06.4, 5, 6, 7, 9, F 07.1, 2,
8, 9 |
Encephalo-asthenic reactions and
states |
Very individually, with the
statement of a psychiatrist or neurologist |
56.
|
F 20-25, F 28-29 |
Schizophrenia, schizotypal
disorders, delirium |
Very individually, with the
statement of a psychiatrist |
57.
|
F 34.1, F 40-42, F 44.0, 1, 4,
5, 6, 7, 9, F 43, 1, 2, 8, 9 |
Neuroses, disorders similar to
neuroses, disorders related to stress and somatoform
disorders |
Very individually, with the
statement of a psychiatrist or neurologist |
58.
|
F 45 |
Somatoform disorders |
Very individually, with the
statement of a psychiatrist or neurologist |
59.
|
F 48 |
Explicit encephalo-asthenic
reactions of various etiology |
Very individually, with the
statement of a psychiatrist or neurologist |
60.
|
F 60-62, F 68, F 90-95, F 98, F
99 |
Personality or behavioural
disorders in the decompensation stage |
Very individually, with the
statement of a psychiatrist |
61.
|
G 00.01 |
Meningococcal or purulent
meningitis of various aetiology |
1 year after clinical and
laboratory remission, with the statement of a
neurologist |
62.
|
G 02 03 |
Serosal meningitis of various
aetiology |
1 year after clinical and
laboratory remission, with the statement of a
neurologist |
63.
|
G 04 05 |
Encephalitis, myelitis,
encephalomyelitis |
1 year after clinical and
laboratory remission |
64.
|
G 12 |
Diseases of the central and
peripheral nervous system with heavy and stable motion,
sensory, or trophic disorders |
Very individually, with the
mandatory statement of a neurologist |
65.
|
G 40, 41 |
Epilepsy with frequent
exacerbations |
Very individually, with the
mandatory statement of a neurologist |
66.
|
G 60-64 |
Polyneuropathy and peripheral
damages to the nervous system |
Permanently |
67.
|
H 10-35.9, 43-45.8, 46-48.8 |
Diseases of the cornea, lens,
outer coat of eye blood vessels, vitreous body, retina, optic
nerve and the eyeball |
Very individually, taking into
account the activity of the disease, with the mandatory
statement of an oculist from the Children's Vision Protection
Centre |
68.
|
H 40 |
Glaucoma |
Very individually, taking into
account the activity of the disease, with the mandatory
statement of an oculist from the Children's Vision Protection
Centre |
69.
|
H 51.2 |
Heavily progressing myopia with
dystrophic changes in the bottom of the eye and significant
decrease in the acuity of vision if the acuity of vision is
equal to impaired vision (not more than 0.2 with correction
in the better-seeing eye) |
Permanently |
70.
|
H 52.2, 55 |
Hypermetropic astigmatism, >
3,0 D, myopic astigmatism, > 4,0 D, nystagmus, if the
acuity of vision is equal to impaired vision (not more than
0.2 with correction in the better-seeing eye) |
Permanently |
71.
|
I 01-07 |
Rheumatism in the active
stage |
1 year |
Rheumatism in the passive stage
with single or combined heart trouble |
With first level heart failure -
1 year after the acute period, with second, third or fourth
level heart failure - permanently |
72.
|
I 10-11 |
Primary arterial
hypertension |
Permanently |
73.
|
I 33 |
Septic endocarditis |
1 year after full clinical and
laboratory remission or 1 year after surgical therapy |
74.
|
I 40 |
Non-rheumatic carditis |
1 year after full clinical and
laboratory remission |
75.
|
I 42.0-42.1 |
Cardiomyopathy |
Permanently |
76.
|
I 44-47 |
Serious heartbeat
disorders: |
|
paroxysmal tachycardia |
6 months after an emerging
attack if the attacks are frequent |
complete atrioventricular
blocking |
Permanently |
a child after the implantation
of an ECS (electrocardio-stimulator) |
Permanently |
77.
|
J 38 |
Diseases of the vocal cords and
larynx |
Permanently |
78.
|
J 42-44.9 |
Non-defined chronic
bronchitis |
Permanently |
79.
|
J 45.0-45.8, J 46 |
Bronchial asthma, grave
course |
Permanently |
80.
|
J 47 |
Bronchiectasis |
6 months after a surgical
operation |
81.
|
J 85-86 |
Purulent and necrotising
respiratory diseases |
6 months after clinical and
laboratory remission |
82.
|
J 84 |
Other interstitial lung
diseases
|
Permanently |
83.
|
K 20-21 |
Chronic esophagitis or
gastro-esophageal reflux disease |
6 months after clinical and
laboratory remission or a surgical operation |
84.
|
K 25-26 |
Gastric or duodenal ulcer or
erosion |
6 months after clinical and
laboratory remission or a surgical operation |
85.
|
K 29 |
Gastritis and duodenitis, with
repeated exacerbations |
6 months after clinical and
laboratory remission or a surgical operation |
86.
|
K 35-36 |
Disease of the appendix |
2 weeks after discharge from
hospital |
87.
|
K 40-46 |
Hernia |
1 month after discharge from
hospital |
88.
|
K 50 |
Crohn's disease |
Permanently |
89.
|
K 51 |
Non-specific ulcerative
colitis |
Permanently |
90.
|
K 56 |
Ileus surgical operations |
1 month after discharge from
hospital |
91.
|
K 90.0 |
Coeliac disease (only refractory
form) |
Permanently |
92.
|
L 20-20.9 |
Atopic dermatitis in the third
stage, exacerbation of chronic atopic dermatitis and the
frequently recidivistic forms thereof |
Permanently |
93.
|
L 40, 40.0, 40.1, 40.3-5,
40.8 |
Psoriasis |
In the exacerbation stage |
94.
|
L 43, 43.0, 43.1, 43.3 |
lichen ruber planus |
Permanently |
95.
|
L 50.8 |
Mastocytosis |
Permanently |
96.
|
L 51 |
Multiform (exudative)
erythema |
In the acute stage |
97.
|
L 63.0-63.9 |
Patchy areas of baldness, total
baldness of the scalp, and other forms of baldness
(alopecia areata, universalis, capitis totalis,
ophiasis, etc. |
Permanently |
98.
|
L 85.0 |
Hereditary ichthyosis |
Permanently |
99.
|
L 94.0-1 |
Scleroderma, confined, diffuse,
with locomotor disorders |
Permanently |
100.
|
M 02 |
Reactive polyarthritis |
6 months after clinical and
laboratory remission |
101.
|
M 08.0-08.9 |
Juvenile chronic arthritis and
juvenile rheumatoid arthritis |
Permanently |
102.
|
M 20-24.9 |
Surgical operations related to
damages to joints |
2 months after the removal of a
plaster cast |
103.
|
M 30, 32-34 |
Systemic lupus erythematosus,
systemic scleroderma, dermatomyositis, periarteritis nodosa,
mixed type or non-differentiated diffuse connective tissue
diseases, systemic vasculitis |
Permanently |
104.
|
M 41-43 |
Surgical related to hereditary
or acquired vertebral column diseases |
2 months after the removal of a
plaster cast |
105.
|
M 86.0 |
Acute hematogenous
osteomyelitis |
3 months after discharge from
hospital |
106.
|
M 87-89 |
Surgical operations related to
bone osteonecrosis and other bone damages |
Until the achievement of
remission, with the statement a nephrologist |
107.
|
N 00-08 |
Glomerular diseases in the acute
stage or the exacerbation stage |
Until the achievement of
remission, with the statement of a nephrologist |
108.
|
N 10-16 |
Tubulointerstitial kidney
damages in the acute stage |
Until the achieving of
remission, with the statement of a nephrologist |
109.
|
N 18-19 |
Chronic renal deficiency (also
with renal replacement therapy) both as an independent
disease and as complications from other diseases |
With the statement of a
nephrologist, individually depending on the clinical status
and catamnesis |
110.
|
N 20, 28.1, 28.8, 36 Q 60,61,
63.0-63.9, 64 |
Renal and urethral diseases and
reconstructive surgical operations |
1 month after discharge from
hospital |
111.
|
Q 20-24 |
Hereditary heart trouble and the
conditions after the surgical operation of hereditary heart
trouble |
Very individually, in
co-ordination with a cardiosurgeon or
cardiorheumatologist |
112.
|
Q 33-34 |
Hereditary lung anomalies and
other respiratory system anomalies |
6 months after a surgical
operation |
113.
|
Q 65-79.9 |
Hereditary support and locomotor
system deformities and deformations |
6 months after a surgical
operation |
114.
|
Q 80, 80.0, 80.3, 80.9 |
Ichthyoses |
Permanently |
115.
|
Q 81, 81.0, 81.2 |
Epidermolysis bullosa |
Permanently |
116.
|
S 05 |
Perforating eyeball injury |
6 months after a trauma |
117.
|
S 06 |
Intracranial injury: brain
concussion (commotio cerebri) |
1-3 years, depending on the
condition, with the statement of a neurologist |
118.
|
S 18.0-20.4 |
Any ear, throat, and nose
surgical operations |
2 months after a surgical
operation |
119.
|
T 10 |
Fractures of large tubular
bones |
With a total period of treatment
during one school year of at least 3 months |
120.
|
T 12, T 12.2, T 12.3 |
Hereditary epidermolysis
bullosa |
Permanently |
121.
|
T 20.3, 20.7, 21.3, 21.7, 22.3,
22.7, 23.3, 23.7, 24.3, 24.7, 25.3, 25.7, 31.1-9, 32.1-9 |
Deep and wide-spread burns |
Not less than 2 months after
discharge from hospital |
Translation © 2005 Tulkošanas un terminoloģijas
centrs (Translation and Terminology Centre)